Switch to:
Biomarin Pharmaceutical Inc (NAS:BMRN)
Other Long-Term Assets
$661.7 Mil (As of Sep. 2014)

Biomarin Pharmaceutical Inc's other long-term assets for the quarter that ended in Sep. 2014 was $661.7 Mil.

Biomarin Pharmaceutical Inc's quarterly other long-term assets increased from Mar. 2014 ($437.6 Mil) to Jun. 2014 ($438.3 Mil) and increased from Jun. 2014 ($438.3 Mil) to Sep. 2014 ($661.7 Mil).

Biomarin Pharmaceutical Inc's annual other long-term assets increased from Dec. 2011 ($333.1 Mil) to Dec. 2012 ($359.2 Mil) and increased from Dec. 2012 ($359.2 Mil) to Dec. 2013 ($575.1 Mil).


Definition

Assets are presented on the balance sheet in order of their liquidity. If a company expects to sell or otherwise recognize the economic value of an asset within one year, the asset is generally classified as a current asset on the balance sheet. Cash on hand is a common current asset.

A long-term asset is an asset that a company expects to sell or otherwise recognize the economic value of after more than one year. Property, plant and equipment, and intangible assets are common long-term assets. Except those two items and current assets, the others we treated as "Other Long Term Assets".


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Biomarin Pharmaceutical Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Other Long-Term Assets 43.752.540.863.315.1185.6379.5333.1359.2575.1

Biomarin Pharmaceutical Inc Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
Other Long-Term Assets 363.8175.2359.2366.4375.2401.3575.1437.6438.3661.7
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK